CAMBRIDGE, Mass. (PRWEB) February 01, 2018
The xME Institute announced today the launch of its new online education platform focused on the interaction of disease pathology and tissue microenvironment. The xME Institute is generating expert curricula on emerging therapies that optimize pathways within the cellular and molecular microenvironment. The Institute’s ACCME-accredited programs give clinicians, scientists, researchers, nurses, and other scientific and medical experts state-of-the-art courses covering late-breaking clinical data and concepts.
“We are thrilled to lead this important educational initiative that is training medical professionals to understand the latest science in how the body’s systems are interconnected,” said Dr. William W. Li, President and Medical Director of the Angiogenesis Foundation. “The xME Institute takes a systems-based approach to understanding how the microenvironment is a common denominator changing the way we understand and treat diseases in areas from immuno-oncology, precision medicine, gene therapy, angiogenesis targeting, and regenerative medicine.”
At the cellular and molecular level, the microenvironment can include blood vessels, immune and inflammatory cells, fibroblasts, stem cells, extracellular matrix, signaling molecules, and a wide range of other cell types and effectors. At the treatment level, the microenvironment lies at the heart of today’s most transformative frontiers in oncology, ophthalmology, wound care, and many other fields. The Institute’s newest CME course highlights the emerging role of biosimilars in oncology. To learn more about the xME Institute or to enroll in its CME programs, visit xmeinstitute.org.